ANI Pharma (ANIP) Tops Q3 EPS by 43c

ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of $1.27, $0.43 better than the analyst estimate of $0.84. Revenue for the quarter came in at $131.83 million versus the consensus estimate of $111.92 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
• Helius Medical Technologies (HSDT) Misses Q2 EPS by 31c